nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.00033	0.00152	CbGpPWpGaD
Acamprosate—Immune system disorder—Capecitabine—kidney cancer	0.00033	0.000422	CcSEcCtD
Acamprosate—Chest pain—Paclitaxel—kidney cancer	0.00033	0.000422	CcSEcCtD
Acamprosate—Arthralgia—Paclitaxel—kidney cancer	0.00033	0.000422	CcSEcCtD
Acamprosate—Myalgia—Paclitaxel—kidney cancer	0.00033	0.000422	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—ANXA1—kidney cancer	0.000329	0.00151	CbGpPWpGaD
Acamprosate—Anxiety—Paclitaxel—kidney cancer	0.000329	0.00042	CcSEcCtD
Acamprosate—Face oedema—Doxorubicin—kidney cancer	0.000329	0.00042	CcSEcCtD
Acamprosate—Decreased appetite—Gemcitabine—kidney cancer	0.000328	0.00042	CcSEcCtD
Acamprosate—Hypersensitivity—Dactinomycin—kidney cancer	0.000328	0.00042	CcSEcCtD
Acamprosate—Chills—Capecitabine—kidney cancer	0.000328	0.000419	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000328	0.000419	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—KCNMA1—kidney cancer	0.000328	0.0015	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000326	0.000417	CcSEcCtD
Acamprosate—Discomfort—Paclitaxel—kidney cancer	0.000326	0.000417	CcSEcCtD
Acamprosate—Gastrointestinal pain—Vincristine—kidney cancer	0.000326	0.000416	CcSEcCtD
Acamprosate—Dizziness—Sorafenib—kidney cancer	0.000324	0.000414	CcSEcCtD
Acamprosate—Pain—Gemcitabine—kidney cancer	0.000323	0.000413	CcSEcCtD
Acamprosate—Constipation—Gemcitabine—kidney cancer	0.000323	0.000413	CcSEcCtD
Acamprosate—Nausea—Erlotinib—kidney cancer	0.000323	0.000413	CcSEcCtD
Acamprosate—Alopecia—Capecitabine—kidney cancer	0.000323	0.000413	CcSEcCtD
Acamprosate—Dry mouth—Paclitaxel—kidney cancer	0.000323	0.000413	CcSEcCtD
Acamprosate—Diarrhoea—Sunitinib—kidney cancer	0.000322	0.000412	CcSEcCtD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000322	0.00148	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000321	0.00147	CbGpPWpGaD
Acamprosate—Mental disorder—Capecitabine—kidney cancer	0.00032	0.000409	CcSEcCtD
Acamprosate—Asthenia—Dactinomycin—kidney cancer	0.00032	0.000409	CcSEcCtD
Acamprosate—Confusional state—Paclitaxel—kidney cancer	0.000319	0.000408	CcSEcCtD
Acamprosate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000319	0.000408	CcSEcCtD
Acamprosate—Malnutrition—Capecitabine—kidney cancer	0.000318	0.000407	CcSEcCtD
Acamprosate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000316	0.000404	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000316	0.00145	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000316	0.00145	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000315	0.00145	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000315	0.00145	CbGpPWpGaD
Acamprosate—Abdominal pain—Vincristine—kidney cancer	0.000315	0.000403	CcSEcCtD
Acamprosate—Body temperature increased—Vincristine—kidney cancer	0.000315	0.000403	CcSEcCtD
Acamprosate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000314	0.000402	CcSEcCtD
Acamprosate—Infection—Paclitaxel—kidney cancer	0.000314	0.000402	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—MAPK3—kidney cancer	0.000314	0.00144	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—POMC—kidney cancer	0.000314	0.00144	CbGpPWpGaD
Acamprosate—Flatulence—Capecitabine—kidney cancer	0.000313	0.000401	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—PAK1—kidney cancer	0.000313	0.00144	CbGpPWpGaD
Acamprosate—Dry skin—Doxorubicin—kidney cancer	0.000312	0.000399	CcSEcCtD
Acamprosate—Dysgeusia—Capecitabine—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—Dizziness—Sunitinib—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—Feeling abnormal—Gemcitabine—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000311	0.00143	CbGpPWpGaD
Acamprosate—Shock—Paclitaxel—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—Vomiting—Sorafenib—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000311	0.000398	CcSEcCtD
Acamprosate—Thrombocytopenia—Paclitaxel—kidney cancer	0.00031	0.000396	CcSEcCtD
Acamprosate—Tachycardia—Paclitaxel—kidney cancer	0.000309	0.000395	CcSEcCtD
Acamprosate—Rash—Sorafenib—kidney cancer	0.000309	0.000394	CcSEcCtD
Acamprosate—Dermatitis—Sorafenib—kidney cancer	0.000308	0.000394	CcSEcCtD
Acamprosate—Back pain—Capecitabine—kidney cancer	0.000308	0.000393	CcSEcCtD
Acamprosate—Breast disorder—Doxorubicin—kidney cancer	0.000308	0.000393	CcSEcCtD
Acamprosate—Skin disorder—Paclitaxel—kidney cancer	0.000307	0.000393	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000307	0.000392	CcSEcCtD
Acamprosate—Headache—Sorafenib—kidney cancer	0.000307	0.000392	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK3—kidney cancer	0.000306	0.00141	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—kidney cancer	0.000306	0.0014	CbGpPWpGaD
Acamprosate—Muscle spasms—Capecitabine—kidney cancer	0.000306	0.000391	CcSEcCtD
Acamprosate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000306	0.000391	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000306	0.0014	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PAK1—kidney cancer	0.000305	0.0014	CbGpPWpGaD
Acamprosate—Diarrhoea—Dactinomycin—kidney cancer	0.000305	0.00039	CcSEcCtD
Acamprosate—Anorexia—Paclitaxel—kidney cancer	0.000301	0.000386	CcSEcCtD
Acamprosate—Gastritis—Doxorubicin—kidney cancer	0.000301	0.000385	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.0003	0.000384	CcSEcCtD
Acamprosate—Vomiting—Sunitinib—kidney cancer	0.000299	0.000383	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—MAPK1—kidney cancer	0.000299	0.00137	CbGpPWpGaD
Acamprosate—Body temperature increased—Gemcitabine—kidney cancer	0.000299	0.000382	CcSEcCtD
Acamprosate—Tremor—Capecitabine—kidney cancer	0.000298	0.000381	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000298	0.00137	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000298	0.00137	CbGpPWpGaD
Acamprosate—Rash—Sunitinib—kidney cancer	0.000297	0.00038	CcSEcCtD
Acamprosate—Dermatitis—Sunitinib—kidney cancer	0.000297	0.000379	CcSEcCtD
Acamprosate—Abdominal distension—Doxorubicin—kidney cancer	0.000296	0.000379	CcSEcCtD
Acamprosate—Hypotension—Paclitaxel—kidney cancer	0.000296	0.000378	CcSEcCtD
Acamprosate—Ill-defined disorder—Capecitabine—kidney cancer	0.000295	0.000377	CcSEcCtD
Acamprosate—Headache—Sunitinib—kidney cancer	0.000295	0.000377	CcSEcCtD
Acamprosate—Dysphagia—Doxorubicin—kidney cancer	0.000294	0.000376	CcSEcCtD
Acamprosate—Asthma—Doxorubicin—kidney cancer	0.000294	0.000376	CcSEcCtD
Acamprosate—Influenza—Doxorubicin—kidney cancer	0.000294	0.000376	CcSEcCtD
Acamprosate—Anaemia—Capecitabine—kidney cancer	0.000294	0.000376	CcSEcCtD
Acamprosate—Hypersensitivity—Vincristine—kidney cancer	0.000293	0.000375	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—MAPK1—kidney cancer	0.000291	0.00134	CbGpPWpGaD
Acamprosate—Eosinophilia—Doxorubicin—kidney cancer	0.000291	0.000372	CcSEcCtD
Acamprosate—Nausea—Sorafenib—kidney cancer	0.000291	0.000372	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—CDKN1B—kidney cancer	0.00029	0.00133	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000289	0.00133	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—kidney cancer	0.000289	0.00133	CbGpPWpGaD
Acamprosate—Pancreatitis—Doxorubicin—kidney cancer	0.000288	0.000369	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000288	0.000368	CcSEcCtD
Acamprosate—GRIN2A—Alzheimers Disease—TP53—kidney cancer	0.000288	0.00132	CbGpPWpGaD
Acamprosate—Malaise—Capecitabine—kidney cancer	0.000287	0.000367	CcSEcCtD
Acamprosate—Angina pectoris—Doxorubicin—kidney cancer	0.000287	0.000366	CcSEcCtD
Acamprosate—Insomnia—Paclitaxel—kidney cancer	0.000286	0.000366	CcSEcCtD
Acamprosate—Vertigo—Capecitabine—kidney cancer	0.000286	0.000365	CcSEcCtD
Acamprosate—Asthenia—Vincristine—kidney cancer	0.000286	0.000365	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—BRAF—kidney cancer	0.000286	0.00131	CbGpPWpGaD
Acamprosate—Syncope—Capecitabine—kidney cancer	0.000285	0.000365	CcSEcCtD
Acamprosate—Leukopenia—Capecitabine—kidney cancer	0.000285	0.000364	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000285	0.00131	CbGpPWpGaD
Acamprosate—Paraesthesia—Paclitaxel—kidney cancer	0.000284	0.000363	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000284	0.0013	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—kidney cancer	0.000283	0.0013	CbGpPWpGaD
Acamprosate—Vomiting—Dactinomycin—kidney cancer	0.000283	0.000362	CcSEcCtD
Acamprosate—Bronchitis—Doxorubicin—kidney cancer	0.000283	0.000362	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—ACHE—kidney cancer	0.000282	0.0013	CbGpPWpGaD
Acamprosate—Dyspnoea—Paclitaxel—kidney cancer	0.000282	0.000361	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—kidney cancer	0.000282	0.00129	CbGpPWpGaD
Acamprosate—Somnolence—Paclitaxel—kidney cancer	0.000281	0.00036	CcSEcCtD
Acamprosate—Palpitations—Capecitabine—kidney cancer	0.000281	0.000359	CcSEcCtD
Acamprosate—Rash—Dactinomycin—kidney cancer	0.000281	0.000359	CcSEcCtD
Acamprosate—Nausea—Sunitinib—kidney cancer	0.00028	0.000358	CcSEcCtD
Acamprosate—Loss of consciousness—Capecitabine—kidney cancer	0.00028	0.000357	CcSEcCtD
Acamprosate—Dyspepsia—Paclitaxel—kidney cancer	0.000278	0.000356	CcSEcCtD
Acamprosate—Cough—Capecitabine—kidney cancer	0.000278	0.000355	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—ACHE—kidney cancer	0.000277	0.00127	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CCND1—kidney cancer	0.000276	0.00127	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000276	0.00127	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000275	0.00126	CbGpPWpGaD
Acamprosate—Decreased appetite—Paclitaxel—kidney cancer	0.000275	0.000352	CcSEcCtD
Acamprosate—Hypertension—Capecitabine—kidney cancer	0.000275	0.000351	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000273	0.00125	CbGpPWpGaD
Acamprosate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000273	0.000349	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—AKAP13—kidney cancer	0.000273	0.00125	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP2—kidney cancer	0.000273	0.00125	CbGpPWpGaD
Acamprosate—Diarrhoea—Vincristine—kidney cancer	0.000272	0.000348	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—kidney cancer	0.000272	0.000348	CcSEcCtD
Acamprosate—Asthenia—Gemcitabine—kidney cancer	0.000271	0.000347	CcSEcCtD
Acamprosate—Arthralgia—Capecitabine—kidney cancer	0.000271	0.000346	CcSEcCtD
Acamprosate—Chest pain—Capecitabine—kidney cancer	0.000271	0.000346	CcSEcCtD
Acamprosate—Myalgia—Capecitabine—kidney cancer	0.000271	0.000346	CcSEcCtD
Acamprosate—Pain—Paclitaxel—kidney cancer	0.00027	0.000346	CcSEcCtD
Acamprosate—Constipation—Paclitaxel—kidney cancer	0.00027	0.000346	CcSEcCtD
Acamprosate—Anxiety—Capecitabine—kidney cancer	0.00027	0.000345	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—RAF1—kidney cancer	0.00027	0.00124	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNA1—kidney cancer	0.000269	0.00124	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000269	0.000344	CcSEcCtD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000269	0.00123	CbGpPWpGaD
Acamprosate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000269	0.000343	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000269	0.00123	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—RELA—kidney cancer	0.000268	0.00123	CbGpPWpGaD
Acamprosate—Weight increased—Doxorubicin—kidney cancer	0.000268	0.000342	CcSEcCtD
Acamprosate—Discomfort—Capecitabine—kidney cancer	0.000268	0.000342	CcSEcCtD
Acamprosate—Pruritus—Gemcitabine—kidney cancer	0.000267	0.000342	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—kidney cancer	0.000266	0.00034	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—BRAF—kidney cancer	0.000266	0.00122	CbGpPWpGaD
Acamprosate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000265	0.000339	CcSEcCtD
Acamprosate—Dry mouth—Capecitabine—kidney cancer	0.000265	0.000339	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—kidney cancer	0.000265	0.000339	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000264	0.00121	CbGpPWpGaD
Acamprosate—Pneumonia—Doxorubicin—kidney cancer	0.000264	0.000337	CcSEcCtD
Acamprosate—Dizziness—Vincristine—kidney cancer	0.000263	0.000337	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—MTOR—kidney cancer	0.000263	0.00121	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—RAF1—kidney cancer	0.000263	0.00121	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNA1—kidney cancer	0.000263	0.0012	CbGpPWpGaD
Acamprosate—Confusional state—Capecitabine—kidney cancer	0.000262	0.000335	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—RELA—kidney cancer	0.000262	0.0012	CbGpPWpGaD
Acamprosate—Feeling abnormal—Paclitaxel—kidney cancer	0.000261	0.000333	CcSEcCtD
Acamprosate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000259	0.000331	CcSEcCtD
Acamprosate—Diarrhoea—Gemcitabine—kidney cancer	0.000258	0.000331	CcSEcCtD
Acamprosate—Infection—Capecitabine—kidney cancer	0.000258	0.00033	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PAX6—kidney cancer	0.000258	0.00118	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—TSC2—kidney cancer	0.000257	0.00118	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MTOR—kidney cancer	0.000257	0.00118	CbGpPWpGaD
Acamprosate—Stomatitis—Doxorubicin—kidney cancer	0.000256	0.000327	CcSEcCtD
Acamprosate—Shock—Capecitabine—kidney cancer	0.000255	0.000327	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—kidney cancer	0.000255	0.000326	CcSEcCtD
Acamprosate—Thrombocytopenia—Capecitabine—kidney cancer	0.000254	0.000325	CcSEcCtD
Acamprosate—Tachycardia—Capecitabine—kidney cancer	0.000253	0.000324	CcSEcCtD
Acamprosate—Vomiting—Vincristine—kidney cancer	0.000253	0.000324	CcSEcCtD
Acamprosate—Skin disorder—Capecitabine—kidney cancer	0.000252	0.000322	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—kidney cancer	0.000252	0.000322	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PAX6—kidney cancer	0.000251	0.00115	CbGpPWpGaD
Acamprosate—Urticaria—Paclitaxel—kidney cancer	0.000251	0.000321	CcSEcCtD
Acamprosate—Rash—Vincristine—kidney cancer	0.000251	0.000321	CcSEcCtD
Acamprosate—Hyperhidrosis—Capecitabine—kidney cancer	0.000251	0.000321	CcSEcCtD
Acamprosate—GRIN1—Alzheimers Disease—TP53—kidney cancer	0.000251	0.00115	CbGpPWpGaD
Acamprosate—Dermatitis—Vincristine—kidney cancer	0.000251	0.000321	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—kidney cancer	0.00025	0.00032	CcSEcCtD
Acamprosate—Abdominal pain—Paclitaxel—kidney cancer	0.00025	0.00032	CcSEcCtD
Acamprosate—Body temperature increased—Paclitaxel—kidney cancer	0.00025	0.00032	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—GRB7—kidney cancer	0.000249	0.00114	CbGpPWpGaD
Acamprosate—Headache—Vincristine—kidney cancer	0.000249	0.000319	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000248	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000248	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000248	0.00114	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000248	0.00114	CbGpPWpGaD
Acamprosate—Epistaxis—Doxorubicin—kidney cancer	0.000247	0.000316	CcSEcCtD
Acamprosate—Anorexia—Capecitabine—kidney cancer	0.000247	0.000316	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—BCHE—kidney cancer	0.000246	0.00113	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TP53—kidney cancer	0.000245	0.00112	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000243	0.00112	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000243	0.00112	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000243	0.00112	CbGpPWpGaD
Acamprosate—Hypotension—Capecitabine—kidney cancer	0.000243	0.00031	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—ACHE—kidney cancer	0.000242	0.00111	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000242	0.00111	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BCHE—kidney cancer	0.000241	0.00111	CbGpPWpGaD
Acamprosate—Vomiting—Gemcitabine—kidney cancer	0.00024	0.000307	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—RAF1—kidney cancer	0.000239	0.00109	CbGpPWpGaD
Acamprosate—Rash—Gemcitabine—kidney cancer	0.000238	0.000305	CcSEcCtD
Acamprosate—Dermatitis—Gemcitabine—kidney cancer	0.000238	0.000304	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000238	0.00109	CbGpPWpGaD
Acamprosate—Haemoglobin—Doxorubicin—kidney cancer	0.000237	0.000303	CcSEcCtD
Acamprosate—Headache—Gemcitabine—kidney cancer	0.000237	0.000303	CcSEcCtD
Acamprosate—Nausea—Vincristine—kidney cancer	0.000237	0.000302	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000236	0.000302	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—kidney cancer	0.000236	0.000302	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—kidney cancer	0.000236	0.000301	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—kidney cancer	0.000236	0.000301	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—JUN—kidney cancer	0.000235	0.00108	CbGpPWpGaD
Acamprosate—Insomnia—Capecitabine—kidney cancer	0.000235	0.0003	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—kidney cancer	0.000234	0.0003	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—kidney cancer	0.000234	0.000299	CcSEcCtD
Acamprosate—GRIN1—BDNF signaling pathway—CTNNB1—kidney cancer	0.000233	0.00107	CbGpPWpGaD
Acamprosate—Paraesthesia—Capecitabine—kidney cancer	0.000233	0.000298	CcSEcCtD
Acamprosate—Hypersensitivity—Paclitaxel—kidney cancer	0.000233	0.000298	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—kidney cancer	0.000232	0.000297	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ITPR2—kidney cancer	0.000232	0.00106	CbGpPWpGaD
Acamprosate—Dyspnoea—Capecitabine—kidney cancer	0.000231	0.000296	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—JUN—kidney cancer	0.000229	0.00105	CbGpPWpGaD
Acamprosate—Dyspepsia—Capecitabine—kidney cancer	0.000228	0.000292	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK3—kidney cancer	0.000228	0.00105	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CTNNB1—kidney cancer	0.000227	0.00104	CbGpPWpGaD
Acamprosate—Visual impairment—Doxorubicin—kidney cancer	0.000227	0.00029	CcSEcCtD
Acamprosate—Asthenia—Paclitaxel—kidney cancer	0.000227	0.00029	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—APC—kidney cancer	0.000227	0.00104	CbGpPWpGaD
Acamprosate—Decreased appetite—Capecitabine—kidney cancer	0.000226	0.000289	CcSEcCtD
Acamprosate—Nausea—Gemcitabine—kidney cancer	0.000224	0.000287	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000224	0.000287	CcSEcCtD
Acamprosate—Pruritus—Paclitaxel—kidney cancer	0.000224	0.000286	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PAK1—kidney cancer	0.000223	0.00103	CbGpPWpGaD
Acamprosate—Pain—Capecitabine—kidney cancer	0.000222	0.000284	CcSEcCtD
Acamprosate—Constipation—Capecitabine—kidney cancer	0.000222	0.000284	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—RAF1—kidney cancer	0.000222	0.00102	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—kidney cancer	0.000222	0.00102	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000221	0.00101	CbGpPWpGaD
Acamprosate—Tinnitus—Doxorubicin—kidney cancer	0.00022	0.000281	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000219	0.001	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—BRAF—kidney cancer	0.000218	0.001	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PAK1—kidney cancer	0.000218	0.001	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000218	0.001	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MAPK1—kidney cancer	0.000217	0.000995	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000217	0.000995	CbGpPWpGaD
Acamprosate—Diarrhoea—Paclitaxel—kidney cancer	0.000216	0.000277	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000214	0.000982	CbGpPWpGaD
Acamprosate—Feeling abnormal—Capecitabine—kidney cancer	0.000214	0.000274	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000214	0.00098	CbGpPWpGaD
Acamprosate—Immune system disorder—Doxorubicin—kidney cancer	0.000213	0.000272	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000213	0.000975	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000213	0.000975	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000213	0.000975	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000212	0.000271	CcSEcCtD
Acamprosate—Chills—Doxorubicin—kidney cancer	0.000211	0.00027	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—BCHE—kidney cancer	0.000211	0.000968	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNA1—kidney cancer	0.00021	0.000965	CbGpPWpGaD
Acamprosate—Dizziness—Paclitaxel—kidney cancer	0.000209	0.000267	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—EIF4EBP1—kidney cancer	0.000209	0.000959	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HSPB1—kidney cancer	0.000209	0.000959	CbGpPWpGaD
Acamprosate—Alopecia—Doxorubicin—kidney cancer	0.000208	0.000266	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000207	0.000951	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000207	0.00095	CbGpPWpGaD
Acamprosate—Mental disorder—Doxorubicin—kidney cancer	0.000206	0.000264	CcSEcCtD
Acamprosate—Urticaria—Capecitabine—kidney cancer	0.000206	0.000264	CcSEcCtD
Acamprosate—Abdominal pain—Capecitabine—kidney cancer	0.000205	0.000262	CcSEcCtD
Acamprosate—Body temperature increased—Capecitabine—kidney cancer	0.000205	0.000262	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—kidney cancer	0.000205	0.000262	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000202	0.000927	CbGpPWpGaD
Acamprosate—Flatulence—Doxorubicin—kidney cancer	0.000202	0.000258	CcSEcCtD
Acamprosate—Tension—Doxorubicin—kidney cancer	0.000201	0.000257	CcSEcCtD
Acamprosate—Vomiting—Paclitaxel—kidney cancer	0.000201	0.000257	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—kidney cancer	0.000201	0.000257	CcSEcCtD
Acamprosate—Rash—Paclitaxel—kidney cancer	0.000199	0.000255	CcSEcCtD
Acamprosate—Dermatitis—Paclitaxel—kidney cancer	0.000199	0.000255	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—kidney cancer	0.000199	0.000255	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000198	0.000911	CbGpPWpGaD
Acamprosate—Back pain—Doxorubicin—kidney cancer	0.000198	0.000254	CcSEcCtD
Acamprosate—Headache—Paclitaxel—kidney cancer	0.000198	0.000253	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—kidney cancer	0.000197	0.000252	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—KDR—kidney cancer	0.000195	0.000894	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSMD7—kidney cancer	0.000194	0.000892	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC1—kidney cancer	0.000194	0.000892	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ANXA1—kidney cancer	0.000194	0.000892	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK3—kidney cancer	0.000194	0.000892	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000193	0.000884	CbGpPWpGaD
Acamprosate—Hypersensitivity—Capecitabine—kidney cancer	0.000191	0.000245	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MET—kidney cancer	0.000191	0.000875	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—BRAF—kidney cancer	0.00019	0.000873	CbGpPWpGaD
Acamprosate—Ill-defined disorder—Doxorubicin—kidney cancer	0.00019	0.000243	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—KDR—kidney cancer	0.00019	0.000872	CbGpPWpGaD
Acamprosate—Anaemia—Doxorubicin—kidney cancer	0.000189	0.000242	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK3—kidney cancer	0.000189	0.000869	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000189	0.000868	CbGpPWpGaD
Acamprosate—Agitation—Doxorubicin—kidney cancer	0.000188	0.000241	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FLT1—kidney cancer	0.000188	0.000864	CbGpPWpGaD
Acamprosate—Nausea—Paclitaxel—kidney cancer	0.000188	0.00024	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000187	0.000858	CbGpPWpGaD
Acamprosate—Asthenia—Capecitabine—kidney cancer	0.000186	0.000238	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MET—kidney cancer	0.000186	0.000853	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—BRAF—kidney cancer	0.000185	0.000851	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK1—kidney cancer	0.000185	0.000848	CbGpPWpGaD
Acamprosate—Malaise—Doxorubicin—kidney cancer	0.000185	0.000236	CcSEcCtD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000184	0.000846	CbGpPWpGaD
Acamprosate—Vertigo—Doxorubicin—kidney cancer	0.000184	0.000236	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—kidney cancer	0.000184	0.000235	CcSEcCtD
Acamprosate—Pruritus—Capecitabine—kidney cancer	0.000184	0.000235	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—kidney cancer	0.000184	0.000235	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—RAF1—kidney cancer	0.000182	0.000836	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TP53—kidney cancer	0.000182	0.000835	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000182	0.000835	CbGpPWpGaD
Acamprosate—Palpitations—Doxorubicin—kidney cancer	0.000181	0.000232	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK1—kidney cancer	0.00018	0.000827	CbGpPWpGaD
Acamprosate—Loss of consciousness—Doxorubicin—kidney cancer	0.00018	0.00023	CcSEcCtD
Acamprosate—Cough—Doxorubicin—kidney cancer	0.000179	0.000229	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000179	0.00082	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RAF1—kidney cancer	0.000178	0.000816	CbGpPWpGaD
Acamprosate—Convulsion—Doxorubicin—kidney cancer	0.000178	0.000227	CcSEcCtD
Acamprosate—Diarrhoea—Capecitabine—kidney cancer	0.000178	0.000227	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—POMC—kidney cancer	0.000178	0.000815	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—RELA—kidney cancer	0.000177	0.000813	CbGpPWpGaD
Acamprosate—Hypertension—Doxorubicin—kidney cancer	0.000177	0.000226	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—kidney cancer	0.000175	0.000223	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—kidney cancer	0.000175	0.000223	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—kidney cancer	0.000175	0.000223	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PAK1—kidney cancer	0.000174	0.000801	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUNB—kidney cancer	0.000174	0.000801	CbGpPWpGaD
Acamprosate—Anxiety—Doxorubicin—kidney cancer	0.000174	0.000222	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—kidney cancer	0.000174	0.000797	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000173	0.000222	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—kidney cancer	0.000172	0.00022	CcSEcCtD
Acamprosate—Dizziness—Capecitabine—kidney cancer	0.000172	0.000219	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—kidney cancer	0.000171	0.000218	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—kidney cancer	0.000169	0.000216	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000167	0.000214	CcSEcCtD
Acamprosate—Infection—Doxorubicin—kidney cancer	0.000166	0.000213	CcSEcCtD
Acamprosate—Vomiting—Capecitabine—kidney cancer	0.000165	0.000211	CcSEcCtD
Acamprosate—Shock—Doxorubicin—kidney cancer	0.000165	0.00021	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—kidney cancer	0.000164	0.000209	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000164	0.000752	CbGpPWpGaD
Acamprosate—Rash—Capecitabine—kidney cancer	0.000164	0.000209	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—MAPK1—kidney cancer	0.000164	0.000751	CbGpPWpGaD
Acamprosate—Dermatitis—Capecitabine—kidney cancer	0.000164	0.000209	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—kidney cancer	0.000163	0.000209	CcSEcCtD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000163	0.000748	CbGpPWpGaD
Acamprosate—Headache—Capecitabine—kidney cancer	0.000163	0.000208	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—kidney cancer	0.000163	0.000208	CcSEcCtD
Acamprosate—GABRB3—Ion channel transport—RAF1—kidney cancer	0.000162	0.000743	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000162	0.000207	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—POMC—kidney cancer	0.000161	0.00074	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000161	0.000738	CbGpPWpGaD
Acamprosate—Anorexia—Doxorubicin—kidney cancer	0.000159	0.000204	CcSEcCtD
Acamprosate—GABRG2—Ion channel transport—RAF1—kidney cancer	0.000159	0.000729	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—RAF1—kidney cancer	0.000159	0.000729	CbGpPWpGaD
Acamprosate—Hypotension—Doxorubicin—kidney cancer	0.000156	0.0002	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000156	0.000716	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—kidney cancer	0.000155	0.000712	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—RAF1—kidney cancer	0.000155	0.00071	CbGpPWpGaD
Acamprosate—Nausea—Capecitabine—kidney cancer	0.000154	0.000197	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—kidney cancer	0.000154	0.000706	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000152	0.000195	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—MAPK1—kidney cancer	0.000152	0.000698	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000152	0.000697	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—kidney cancer	0.000151	0.000194	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—kidney cancer	0.00015	0.000192	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—kidney cancer	0.000149	0.000191	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—kidney cancer	0.000149	0.00019	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—kidney cancer	0.000147	0.000188	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—kidney cancer	0.000145	0.000186	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000144	0.000185	CcSEcCtD
Acamprosate—Pain—Doxorubicin—kidney cancer	0.000143	0.000183	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—kidney cancer	0.000143	0.000183	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IGF2—kidney cancer	0.000143	0.000655	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000142	0.000652	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN2B—kidney cancer	0.000142	0.000652	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RAF1—kidney cancer	0.000141	0.000647	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000141	0.000645	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ERBB2—kidney cancer	0.000139	0.00064	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—kidney cancer	0.000139	0.000638	CbGpPWpGaD
Acamprosate—GABRA1—Ion channel transport—RAF1—kidney cancer	0.000139	0.000637	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000139	0.000636	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1R—kidney cancer	0.000138	0.000633	CbGpPWpGaD
Acamprosate—Feeling abnormal—Doxorubicin—kidney cancer	0.000138	0.000176	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—RAF1—kidney cancer	0.000137	0.00063	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000137	0.000175	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000137	0.000628	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—kidney cancer	0.000136	0.000625	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—kidney cancer	0.000136	0.000624	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—kidney cancer	0.000136	0.000622	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000134	0.000616	CbGpPWpGaD
Acamprosate—Urticaria—Doxorubicin—kidney cancer	0.000133	0.00017	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—RAF1—kidney cancer	0.000133	0.00061	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—kidney cancer	0.000133	0.000609	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—kidney cancer	0.000132	0.000169	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—kidney cancer	0.000132	0.000169	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—IL2—kidney cancer	0.000131	0.000602	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000131	0.000599	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000128	0.000588	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	0.000128	0.000588	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000126	0.000579	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BRAF—kidney cancer	0.000125	0.000576	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—kidney cancer	0.000125	0.000573	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000125	0.000573	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000125	0.000573	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000124	0.000569	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000124	0.000568	CbGpPWpGaD
Acamprosate—Hypersensitivity—Doxorubicin—kidney cancer	0.000123	0.000158	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—BRAF—kidney cancer	0.000123	0.000565	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000123	0.000562	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	0.000122	0.00056	CbGpPWpGaD
Acamprosate—Asthenia—Doxorubicin—kidney cancer	0.00012	0.000153	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—IL2—kidney cancer	0.000119	0.000547	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—kidney cancer	0.000118	0.000151	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000117	0.000539	CbGpPWpGaD
Acamprosate—Diarrhoea—Doxorubicin—kidney cancer	0.000114	0.000146	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—HIF1A—kidney cancer	0.000114	0.000521	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC2—kidney cancer	0.000113	0.00052	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000112	0.000514	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—kidney cancer	0.000111	0.000141	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000109	0.000501	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—kidney cancer	0.000109	0.0005	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—kidney cancer	0.000109	0.000498	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000108	0.000497	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—kidney cancer	0.000108	0.000494	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—kidney cancer	0.000107	0.000493	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000107	0.000491	CbGpPWpGaD
Acamprosate—Vomiting—Doxorubicin—kidney cancer	0.000106	0.000136	CcSEcCtD
Acamprosate—GRIN2B—Neuronal System—MAPK1—kidney cancer	0.000106	0.000487	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—kidney cancer	0.000105	0.000135	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—kidney cancer	0.000105	0.000135	CcSEcCtD
Acamprosate—Headache—Doxorubicin—kidney cancer	0.000105	0.000134	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—RAF1—kidney cancer	0.000105	0.000481	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—kidney cancer	0.000105	0.00048	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—RAF1—kidney cancer	0.000103	0.000472	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—kidney cancer	0.000102	0.000466	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RAF1—kidney cancer	0.000101	0.000461	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RELA—kidney cancer	0.0001	0.000459	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—kidney cancer	0.0001	0.000459	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—kidney cancer	0.0001	0.000459	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.96e-05	0.000457	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—kidney cancer	9.95e-05	0.000457	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—kidney cancer	9.94e-05	0.000127	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MAPK3—kidney cancer	9.9e-05	0.000454	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAF1—kidney cancer	9.8e-05	0.00045	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.78e-05	0.000449	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RELA—kidney cancer	9.76e-05	0.000448	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—kidney cancer	9.7e-05	0.000445	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—kidney cancer	9.67e-05	0.000444	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—kidney cancer	9.58e-05	0.00044	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—kidney cancer	9.52e-05	0.000437	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—kidney cancer	9.42e-05	0.000432	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—kidney cancer	9.4e-05	0.000431	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.38e-05	0.00043	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.21e-05	0.000423	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—kidney cancer	9.13e-05	0.000419	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—kidney cancer	9.12e-05	0.000418	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—RAF1—kidney cancer	8.99e-05	0.000413	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—kidney cancer	8.9e-05	0.000408	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—kidney cancer	8.71e-05	0.0004	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—kidney cancer	8.7e-05	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—kidney cancer	8.61e-05	0.000395	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.55e-05	0.000392	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—kidney cancer	8.49e-05	0.000389	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	8.05e-05	0.000369	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—kidney cancer	7.91e-05	0.000363	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAF1—kidney cancer	7.85e-05	0.00036	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RELA—kidney cancer	7.82e-05	0.000359	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—kidney cancer	7.77e-05	0.000356	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—kidney cancer	7.67e-05	0.000352	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—kidney cancer	7.66e-05	0.000352	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—kidney cancer	7.47e-05	0.000343	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—kidney cancer	7.25e-05	0.000333	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—kidney cancer	7.19e-05	0.00033	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—kidney cancer	7.19e-05	0.00033	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—kidney cancer	7.07e-05	0.000324	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—kidney cancer	7.06e-05	0.000324	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—kidney cancer	7.04e-05	0.000323	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—kidney cancer	6.9e-05	0.000316	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—kidney cancer	6.86e-05	0.000315	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—kidney cancer	6.85e-05	0.000314	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—kidney cancer	6.8e-05	0.000312	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—kidney cancer	6.72e-05	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—kidney cancer	6.62e-05	0.000304	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—kidney cancer	6.51e-05	0.000299	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—kidney cancer	6.35e-05	0.000291	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—kidney cancer	6.17e-05	0.000283	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—kidney cancer	5.98e-05	0.000275	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—kidney cancer	5.66e-05	0.00026	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	5.63e-05	0.000259	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.53e-05	0.000254	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—kidney cancer	5.5e-05	0.000253	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—kidney cancer	5.39e-05	0.000247	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—kidney cancer	5.09e-05	0.000233	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.84e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—kidney cancer	4.67e-05	0.000214	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—kidney cancer	4.52e-05	0.000207	CbGpPWpGaD
